Literature DB >> 19654496

Resolution of rheumatoid arthritis symptoms with imatinib mesylate.

Matthew R Vernon, Larry Pearson, Ehab Atallah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19654496     DOI： 10.1097/RHU.0b013e3181b0d352

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  3 in total

Review 1.  Cellular targeting in autoimmunity.

Authors:  Jennifer L Rogers; Donald S Serafin; Roman G Timoshchenko; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

2.  A computational approach to finding novel targets for existing drugs.

Authors:  Yvonne Y Li; Jianghong An; Steven J M Jones
Journal:  PLoS Comput Biol       Date:  2011-09-01       Impact factor: 4.475

3.  Imatinib might constitute a treatment option for lung involvement in COVID-19.

Authors:  David Bernal-Bello; Beatriz Jaenes-Barrios; Alejandro Morales-Ortega; José Manuel Ruiz-Giardin; Virginia García-Bermúdez; Begoña Frutos-Pérez; Ana Isabel Farfán-Sedano; Cristina de Ancos-Aracil; Fernando Bermejo; Mario García-Gil; Antonio Zapatero-Gaviria; Juan Víctor San Martín-López
Journal:  Autoimmun Rev       Date:  2020-05-03       Impact factor: 9.754
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.